A detailed history of Acadian Asset Management LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 946,840 shares of SAGE stock, worth $5.43 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
946,840
Previous 586 161476.79%
Holding current value
$5.43 Million
Previous $6,000 113783.33%
% of portfolio
0.02%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$7.02 - $13.08 $6.64 Million - $12.4 Million
946,254 Added 161476.8%
946,840 $6.83 Million
Q2 2024

Aug 06, 2024

BUY
$10.58 - $17.9 $6,199 - $10,489
586 New
586 $6,000
Q2 2022

Aug 09, 2022

SELL
$27.52 - $37.99 $4.98 Million - $6.88 Million
-180,979 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$30.71 - $45.71 $8.49 Million - $12.6 Million
-276,601 Reduced 60.45%
180,979 $5.99 Million
Q4 2021

Feb 10, 2022

BUY
$37.06 - $47.11 $2.9 Million - $3.69 Million
78,335 Added 20.66%
457,580 $19.5 Million
Q3 2021

Nov 12, 2021

BUY
$40.26 - $57.37 $7.13 Million - $10.2 Million
177,102 Added 87.61%
379,245 $16.8 Million
Q2 2021

Aug 11, 2021

BUY
$54.88 - $79.29 $5.99 Million - $8.65 Million
109,093 Added 117.24%
202,143 $11.5 Million
Q1 2021

May 11, 2021

BUY
$70.65 - $96.76 $6.55 Million - $8.97 Million
92,691 Added 25819.22%
93,050 $6.97 Million
Q4 2020

Feb 11, 2021

BUY
$58.41 - $89.06 $20,969 - $31,972
359 New
359 $31,000
Q3 2020

Nov 09, 2020

SELL
$41.13 - $62.45 $25,253 - $38,344
-614 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$25.95 - $43.15 $15,933 - $26,494
614 New
614 $26,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $340M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.